LOAD MORE
You're viewed all 13 products
The factors influencing the synthesis of Ruxolitinib impurities include the choice of starting materials, reaction conditions, solvent choice, temperature, and catalysts.
The degradation impurities in Ruxolitinib may include impurities formed due to chemical or physical degradation of the drug, such as hydrolysis, oxidation, and photodegradation.
Analytical techniques such as high-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), etc., help identify and quantify Ruxolitinib impurities.
Ruxolitinib impurities are isolated and purified using techniques, column chromatography, recrystallization, and preparative HPLC.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.